Evidence map›Paper›PMID 31297067›Full record

ReviewFrontiers in physiology2019

The Use of Tick Salivary Proteins as Novel Therapeutics.

Jindřich Chmelař, Jan Kotál, Anna Kovaříková, Michail Kotsyfakis

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pathogens (Basel, Switzerland) · 2025
    Article
  5. Serpins in the Spotlight: Novel Bioinformatic Insights IntoBiochemistry research international · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Journal of arthropod-borne diseases · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Pathogens (Basel, Switzerland) · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jindřich ChmelařDepartment of Medical Biology, Faculty of Science, University of South Bohemia in České Budějovice, České Budějovice, Czechia.
Jan KotálDepartment of Medical Biology, Faculty of Science, University of South Bohemia in České Budějovice, České Budějovice, Czechia.
Anna KovaříkováDepartment of Medical Biology, Faculty of Science, University of South Bohemia in České Budějovice, České Budějovice, Czechia.
Michail KotsyfakisDepartment of Medical Biology, Faculty of Science, University of South Bohemia in České Budějovice, České Budějovice, Czechia.
University of South Bohemia in České Budějovice · CZInstitute of Parasitology · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The last three decades of research into tick salivary components have revealed several proteins with important pharmacological and immunological activities. Two primary interests have driven research into tick salivary secretions: the search for suitable pathogen transmission blocking or "anti-tick" vaccine candidates and the search for novel therapeutics derived from tick salivary components. Intensive basic research in the field of tick salivary gland transcriptomics and proteomics has identified several major protein families that play important roles in tick feeding and overcoming vertebrate anti-tick responses. Moreover, these families contain members with unrealized therapeutic potential. Here we review the major tick salivary protein families exploitable in medical applications such as immunomodulation, inhibition of hemostasis and inflammation. Moreover, we discuss the potential, opportunities, and challenges in searching for novel tick-derived drugs.

Indexed as

anti-inflammatory proteinshemostasisimmunomodulationsalivary proteinstherapeuticsticks

Identifiers

PMID31297067
PMCPMC6607933
OpenAlexW2953855422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.